Bristol-Myers Squibb Co at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs, and we're very pleased to welcome Bristol-Myers Squibb today to our virtual conference.
Joining us from the company is Nadim Ahmed, who is Executive Vice President and President of Hematology; Chris Boerner, who's Executive Vice President and Head of Commercial -- Chief Commercial Officer. Looking forward to hosting you both today. Thank you for taking time out of your day to join us.
Questions & Answers
Maybe just to get started, and again, maybe, Chris, this one would be for you. And, then, Nadim, you could add on anything here. We're obviously into June, and some states are starting to reopen now. And just wanted to check in on the operating environment and how that's tracking relative to the expectations that you outlined on your first quarter call, where you said you saw more -- a return to a more stable
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
